Stereotaxis, Inc.

AMEX:STXS

Medical - Instruments & Supplies

Healthcare
$0.95 +2.53%

+$0.05 today

Market cap
$94.80M
Beta
1.32
P/E (TTM)
-8.3
EPS (TTM)
-$0.22
52W Low $1.70High $3.59

Volume 0.90M

Average 0.39M

STXS Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Stereotaxis, Inc.AMEX: STXS

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue dips below year-ago levels

Q1 FY2026 cost of revenue of $2.5M fell 26.7% year over year, behind the +12.3% change in trailing-twelve-month cost of revenue. Sequentially, it fell 42.1% from the prior quarter. Over 3 fiscal years it compounded at +16.5% a year.

Context

  • Cost of revenue amounted to 47.3% of revenue in FY2025, up 1.5 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -26.7% toward the trailing-twelve-month pace of +12.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.5M-42.1% QoQ
Last fiscal yearDec 2025
$15.31M+24.2% YoY
LTMMar 2026
$14.39M+12.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-26.7%——
1 year+24.2%——
3-year CAGR+16.5%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
15.31M USD
Year-over-year change
+24.2%
4-year CAGR
+6.7%

Cost of Revenue vs competitors

How STXS compares with its peers on the latest reported figures

  • STXS's LTM Mar 2026 cost of revenue of $14.39M is the 4th highest of the 5 companies compared; the peer median is $18.55M.
  • Its year-over-year change of +12.3% is the 4th highest of 5, against a peer median of +63.3%.
  • Cost of revenue amounts to 46.1% of revenue for STXS, versus a peer median of 44.9%.
STXS Competitors Peer median
Cost of Revenue for STXS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SSIISS Innovations International, Inc.LTM Mar 2026$25M +102.6%+187.2%51.6%
NPCENeuroPace, Inc.LTM Mar 2026$21.6M +1.8%+20.5%21.7%
CLPTClearPoint Neuro, Inc.LTM Mar 2026$15.51M +24.0%+26.7%38.2%
STXSStereotaxis, Inc.LTM Mar 2026$14.39M +12.3%+16.5%46.1%
MBOTMicrobot Medical Inc.LTM Mar 2026$115K +342.3%—109.5%
Peer median (excluding STXS) $18.55M+63.3%+26.7%44.9%

Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue35.02M28.15M26.77M26.92M32.38M
Cost of Revenue11.79M9.68M11.91M12.32M15.31M
Gross Profit23.23M18.47M14.86M14.59M17.07M
Gross Margin66.3%65.6%55.5%54.2%52.7%
Research & Development10.2M10.56M10.27M9.76M9.38M
Selling, General & Admin25.92M26.69M26.43M29.57M30.29M
Operating Expenses36.12M37.25M36.7M39.33M39.18M
Depreciation & Amortization106K429K595K969K1.56M
EBITDA(10.6M)(17.86M)(20.12M)(23.08M)(20.09M)
EBITDA Margin-30.3%-63.5%-75.1%-85.7%-62.0%
Operating Income(12.89M)(18.78M)(21.84M)(24.74M)(22.11M)
Operating Margin-36.8%-66.7%-81.6%-91.9%-68.3%
Interest Income0484K1.1M694K467K
Interest Expense10.07K0000
Other Income / Expenses2.17M484K1.13M694K469K
Income Before Tax(10.72M)(18.29M)(20.71M)(24.05M)(21.64M)
Pre-Tax Margin-30.6%-65.0%-77.4%-89.3%-66.8%
Income Tax Expense00000
Net Income(10.72M)(18.29M)(20.71M)(24.05M)(21.64M)
Net Margin-30.6%-65.0%-77.4%-89.3%-66.8%
EPS (Basic)(0.16)(0.26)(0.27)(0.30)(0.25)
EPS (Diluted)(0.16)(0.26)(0.27)(0.30)(0.25)
Weighted Avg Shares75.56M76.06M80.7M85.18M90.96M
Weighted Avg Shares (Diluted)75.56M76.06M80.7M85.18M90.96M

Stereotaxis, Inc.

AMEX:STXS

Intrinsic Alpha fair value

Locked

Current Price

$0.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.